Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process
Authors
Soonryu Seo (ORCID: https://orcid.org/0000-0001-6252-8984)
Hyungseok Kang (ORCID: https://orcid.org/0000-0002-9175-0012)
Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process
Soonryu Seo, Hyungseok Kang, Jung Eun Shin, Tae Sun Shim et al.
Journal
BMC Infectious Diseases
Topics
Tuberculosis Research and Epidemiology
article
Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process
Soonryu Seo, Hyungseok Kang, Jung Eun Shin, Tae Sun Shim, Su Jin Hong, Yong-Soo Kwon, Hyeontaek Hwang, Doosoo Jeon, Jae-Joon Yim, Mi Ri Jang, Jeongha Mok
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC Infectious Diseases
Institutions
Seoul National University (KR), Yonsei University (KR), Seoul National University Hospital (KR), Seoul National University Bundang Hospital (KR), University of Ulsan (KR), Chonnam National University Hospital (KR), Pusan National University Hospital (KR), National University College (PR), Masan National Tuberculosis Hospital (KR), Korea Disease Control and Prevention Agency (KR), Pusan National University Yangsan Hospital (KR), Pusan National University (KR)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Outcomes in patients with multidrug- or rifampin-resistant tuberculosis treated with bedaquiline and/or delamanid under the South Korean nationwide approval process — Soonryu Seo, Hyungseok Kang, et al. · BMC Infectious Diseases (2026) | TGRS Research Map | TGRS